key: cord-0728714-z10soxma
authors: Chen, Ziqi; Lv, Yiwen; Xu, Huachong; Deng, Li
title: Herbal Medicine, Gut Microbiota, and COVID-19
date: 2021-07-07
journal: Front Pharmacol
DOI: 10.3389/fphar.2021.646560
sha: 35560ffad14c691b037f58734f93e14ce21e0a9a
doc_id: 728714
cord_uid: z10soxma

Coronavirus Disease 19 (COVID-19) is a respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has grown to a worldwide pandemic with substantial mortality. The symptoms of COVID-19 range from mild flu-like symptoms, including cough and fever, to life threatening complications. There are still quite a number of patients with COVID-19 showed enteric symptoms including nausea, vomiting, and diarrhea. The gastrointestinal tract may be one of the target organs of SARS-CoV-2. Angiotensin converting enzyme 2 (ACE2) is the main receptor of SARS-CoV-2 virus, which is significantly expressed in intestinal cells. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Intestinal flora imbalance and endotoxemia may accelerate the progression of COVID-19. Many herbs have demonstrated properties relevant to the treatment of COVID-19, by supporting organs and systems of the body affected by the virus. Herbs can restore the structure of the intestinal flora, which may further modulate the immune function after SARS-CoV-2 infection. Regulation of intestinal flora by herbal medicine may be helpful for the treatment and recovery of the disease. Understanding the role of herbs that regulate intestinal flora in fighting respiratory virus infections and maintaining intestinal flora balance can provide new ideas for preventing and treating COVID-19.

Coronaviruses are mainly divided into four genera, alpha (α), beta (β), gamma (γ), and delta (δ), which can infect humans and a variety of animals. The seven human coronaviruses (HCoV) that have been discovered are HCoV-229E, HCoV-NL63, HCoV-OC43, HCoV-HKU1, Severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and SARS-CoV-2. Coronaviruses can cause respiratory as well as gastrointestinal infections in humans and animals (Su et al., 2016) . In addition to the respiratory system, the digestive tract is most commonly affected by coronavirus infections. The symptoms mainly include abdominal pain, nausea, vomiting, and diarrhea. Human gastrointestinal cells were highly susceptible to MERS-CoV, and the virus was able to maintain their replication robustly in small intestine cells (Xiong et al., 2020) . About 1/3 of patients with Middle East respiratory syndrome (MERS) have gastrointestinal symptoms (Matoba et al., 2015; Corman et al., 2018) . SARS-CoV-2 is an enveloped, positively charged single-stranded RNA virus belonging to the genus Coronavirus. SARS-CoV-2 is highly homologous to SARS coronavirus, and its nucleic acid sequence similarity reaches 70%. Similar to SARS virus infection, respiratory tract infection symptoms such as fever and cough are one of the most common clinical manifestations of COVID-19 patients . Still, a considerable number of patients will also have gastrointestinal symptoms such as diarrhea .

Angiotensin-converting enzyme 2 (ACE2) is the primary receptor of the SARS-Cov-2 virus. ACE2 is significantly expressed in alveolar type II cells and intestinal cells (Hashimoto et al., 2012) . Current studies believe that the gastrointestinal tract is one of the target organs of SARS-CoV-2 (Jin et al., 2020a) . The positive viral RNA test in the stool of COVID-19 patients also confirms this to a certain extent and suggests SARS-CoV-2 transmission through the fecal-oral route. It undoubtedly poses a further challenge to the prevention and control of the COVID-19 epidemic. Although the respiratory symptoms related to COVID-19 have attracted significant attention, gastrointestinal symptoms are often overlooked, which can easily lead to a missed diagnosis. This review summarizes COVID-19, SARS, and MERS's clinical features associated with gastrointestinal symptoms, the related mechanisms of changes in the intestinal flora, and related herbs that can regulate intestinal flora. Understanding the gastrointestinal symptoms and possible mechanisms of COVID-19 is of great clinical significance for the early diagnosis, treatment, and control of the disease.

COVID-19 is mainly manifested by fever, fatigue, and dry cough, but some patients have abdominal pain, nausea, vomiting, diarrhea, and other symptoms. According to relevant reports on COVID-19 symptoms, the number, range, and severity of COVID-19-related symptoms may vary from person to person. Overall, our symptom analysis of independently published studies (Booth et al., 2003; Chan et al., 2003; Choi et al., 2003; Lee et al., 2003; Peiris et al., 2003a; Peiris et al., 2003b; Poutanen et al., 2003; Rainer et al., 2003; Tsang et al., 2003; Zaki et al., 2012; Assiri et al., 2013a; Assiri et al., 2013b; Memish et al., 2013; Al-Tawfiq et al., 2014; Saad et al., 2014; Noorwali et al., 2015; Oboho et al., 2015; Yin and Wunderink, 2018; Cattelan et al., 2020; Chen et al., 2020; Cummings et al., 2020; Guan et al., 2020a; Guan et al., 2020b; Li et al., 2020a; Qian et al., 2020; Shi S. et al., 2020; Suleyman et al., 2020; Wang D. et al., 2020; Xu X. et al., 2020; Zhang et al., 2020a; Zhou et al., 2020) involving thousands of people shows that a small proportion but large number of patients experience gastrointestinal problems (Figure 1) .

Among the 1,299 hospitalized patients with SARS included in the statistics, 514 (39%) developed gastrointestinal symptoms, included diarrhea (7-20%) (Booth et al., 2003; Chan et al., 2003; Peiris et al., 2003b; Tsang et al., 2003) , there are also reports that a 50% (Poutanen et al., 2003) probability of appearing, nausea or vomiting (12-20%) Yin and Wunderink, 2018) . Similarly, in every two of the MERS inpatients, a gastrointestinal symptom occurs. Including loss of appetite (4-6%) (Assiri et al., 2013b; Oboho et al., 2015) , nausea or vomiting (7-28%) (Assiri et al., 2013a; Oboho et al., 2015; Yin and Wunderink, 2018) , abdominal pain (3-24%) (Assiri et al., 2013b; Memish et al., 2013) and diarrhea (5-30%) (Al-Tawfiq et al., 2014; Saad et al., 2014) , the incidence of diarrhea was also reported as 75% (Memish et al., 2013) . Consistent with SARS-CoV-1 and MERS-CoV, among a total of 7,322 COVID-19 patients, 1,104 patients suffered gastrointestinal problems, as high as 15% of cases. According to the report, 9-26% (Qian et al., 2020; Suleyman et al., 2020) patients loss their appetite (median 17%), 2-31% had diarrhea (median 9.8%) with an outlier of the 40% and 4-30% (Li et al., 2020b; Xu X. et al., 2020; Zhou et al., 2020) suffered from nausea or vomiting (median 6%). Incidence of gastrointestinal complaints, vomiting, and diarrhea caused by SARS-CoV-2 is similar to SARS-CoV-1 and MERS-CoV. Patients in severe or critical condition have the highest incidence of diarrhea (Guan et al., 2020b) . In rare cases Pan et al., 2020) , diarrhea is the only symptom of COVID-19. The autopsy study of patients who died of COVID-19 also found that the small intestine showed segmental dilation and narrow changes (Wichmann et al., 2020) . It is shown that the SARS-CoV-2 attacks not only the lungs but also the GI track. Theoretically, SARS-CoV-2 can bind to the angiotensin-converting enzyme 2 (ACE2) receptors in the intestinal cells, thus causing gastrointestinal disease and gastrointestinal symptoms such as abdominal pain and diarrhea.

At present, SARS-CoV-2 has been found and isolated in stool samples of patients with COVID-19 (Tang et al., 2020; Mohan et al., 2021) , and changes in intestinal flora have been found in COVID-19 patients with gastrointestinal symptoms (Dhar and Mohanty, 2020) . It is suggested that SARS-CoV-2 may cause intestinal flora imbalance while causing lung infection. The intestinal flora is composed of bacteria, viruses, fungi, and archaea. Viral infections can cause changes in the composition of intestinal flora, thereby causing intestinal barrier disfunction (Eckburg et al., 2005; Qin et al., 2015; Thaiss et al., 2016; Deng et al., 2020) . Intestinal flora has a closely relationship with the expression of tight junction proteins in the intestinal epithelial cells. The dysbiosis of intestinal flora is accompanied by decreased expression of intestinal tight junction proteins such as Claudin-1, Occludin and ZO-1, leading to the disruption of intestinal barrier. The intestinal barrier function requires the complexity of epithelial, which relies on the differentiation of intestinal stem cells . ACE2 may dictate the stemness of intestinal stem cells by orchestrating calcium perturbation . For patients in severe or critical condition, the disordered intestinal flora leads to abnormal intestinal inflammation, which affects the gut-lung axis and aggravates the degree of systemic inflammation during the disease (Schuijt et al., 2016; Zhu et al., 2018) . Unstable gut mycobiomes and prolonged dysbiosis persisted in patients with COVID-19 after nasopharyngeal clearance of SARS-CoV-2 (Zuo et al., 2020) . A. flavus and Aspergillus niger, were detected in fecal samples from patients with COVID-19, even after clearance of SARS-CoV-2 from nasopharyngeal samples and resolution of respiratory symptoms (Zuo et al., 2020) . In patients with SARS-CoV-2 infection accompanied by abdominal pain, diarrhea and other gastrointestinal symptoms, the probiotics such as Lactobacillus or Bifidobacterium in the intestines are significantly reduced . Nutritional support, and supplementation of probiotics can reduce bacterial translocation and secondary intestinal infections (Dhar and Mohanty, 2020) . China's Guidelines for the diagnosis and treatment of novel coronavirus pneumonia (version sixth) mentioned that herbal medicine with prebiotic effect could be used to maintain the intestinal flora homeostasis and prevent secondary bacterial infections.

The SARS-CoV-2 Spike Glycoprotein can bind to the ACE2 receptor on intestinal epithelial cells' surface (Walls et al., 2020) . ACE2 is expressed in lung cells and intestinal epithelial cells of the esophagus, ileum, and colon. According to the combined data from human protein atlas (http://www. proteinatlas.org), genotype tissue expression and mammalian genome function annotations, the top three tissues with the highest expression levels belong to intestinal tissues ( Figure 2) . Therefore, SARS-CoV-2 not only infects the respiratory system but may also directly affect the GI system. ACE2 controls the functional expression in the intestines of one of the transport proteins, B0AT1, which acts specifically on neutral amino acids. (Scalise and Indiveri, 2020) . The ACE2-B0AT1 exists as a dimer of heterodimers.

Deficiency of ACE2 can also causes a critical impairment of local tryptophan homeostasis which alters the susceptibility to intestinal inflammation (Vuille-dit-Bille et al., 2015) . Dietary tryptophan is primarily absorbed via the B0AT1/ACE2 transport pathway on the luminal surface of small intestinal epithelial cells. These differences were reduced when the diet of the ACE2 mutant mice was supplemented with a source of tryptophan (Izcue and Powrie, 2012) . Tryptophan has major effects on the host and notably on immunity and metabolism, gut microbiota, intestinal barrier, and transit (Gao et al., 2018; Taleb, 2019) . Under normal physiological conditions, the barrier function of the intestinal mucosa is relatively complete, which can effectively prevent the invasion of harmful substances and maintain the stability of the body environment. The intestinal mucosal immune barrier is composed of gut associated lymphoid tissue (GALT) and diffuse immune cells (mainly refers to lamina propria lymphocytes and intraepithelial lymphocytes). GALT can bind to the antigen to produce secretory immunoglobulin A (SIgA). Intestinal mucosal intraepithelial lymphocytes (IEL) and lamina propria lymphocytes (LPL) is the efferent effect and regulatory site of the mucosal immune system (Qiao et al., 1991; Abuzakouk et al., 1998) . The stimulated IEL (mainly T lymphocytes) can proliferate rapidly and release a variety of cytokines such as IL-2, IFN-γ, TNF-α. It has the functions of defense against intestinal pathogen invasion, anti-mucosal allergic reaction, suppression of immune response, elimination of damaged epithelial cells and promotion the production of SIgA (Viney and MacDonald, 1990; Olivares-Villagomez and Van Kaer, 2018) . LPL (mainly T lymphocytes, B lymphocytes, macrophages, dendritic cells) can secrete a variety of Th2-type cytokines such as TNF, IL-4, IL-6, and IL-10. It contains a large number of plasma cells, which can promote the secretion of Ig A antibodies, neutralize and eliminate antigens. SIgA dimer exists on the surface of the gastrointestinal mucosa and is the main effector molecule of the intestinal mucosal immune response. It can prevent the invasion and adhesion of pathogens, and can bind the corresponding antigen to inhibit bacterial proliferation and neutralize toxins, and can resist proteolytic enzymes. Protect the intestinal mucosa from being digested, and exert local antiinfection and anti-allergic effects (Pal et al., 2013; Zhang J. et al., 2020) .

In the absence of ACE2, the expression of the mTOR signaling pathway in the small intestine is reduced, resulting in a decrease in the expression of antimicrobial peptides in the Paneth cells of the small intestine (Hashimoto et al., 2012) . The antimicrobial peptides in Paneth cells in the small intestine can change the composition of the intestinal flora and increase intestinal inflammation. Inhibition of the expression of antimicrobial peptides will lead to a sharp increase in the probability of endotoxin and endogenous infection, thereby producing and promoting inflammatory mediators. The cascade reaction caused by the inhibition of the expression of antimicrobial peptides leads to extensive tissue damage, gastrointestinal symptoms, and even multiple organ failure (MOF), leading to a poor prognosis for COVID-19 patients.

As a carboxypeptidase, ACE2 can catalyze Ang Ⅱ to Ang (1-7), which further binds to the cell surface receptor MAS to establish a second axis through ACE2/ANG-(1-7)/MAS, whose end point is the metabolite ANG-(1-7). The downstream ERK, P38, and JNK signaling pathways are regulated by Mas, which plays a protective role in inhibiting the inflammatory response (Passos-Silva et al., 2013) . Besides, Ang (1-7) can also directly inhibit or promote the release of nitric oxide from intestinal smooth muscle cells through Mas receptors , thereby intervening in the activation Ang (1-7) of NF-κB signaling pathways and reducing intestinal inflammatory damage (Souza Santos et al., 2018) .

Restore the intestinal flora and reduce the intestinal barrier disruption may be of great value in preventing and treating SARS-CoV-2 infection. The intestinal flora can affect the occurrence of respiratory diseases through the production of metabolites (Saint-Georges-Chaumet and Edeas, 2016). A variety of specific microorganisms in the intestine can ferment undigested carbohydrates in the small intestine, produce shortchain fatty acids, and participate in energy metabolism (den Besten et al., 2013; Koeth et al., 2013; Ridaura et al., 2013; Koh et al., 2016) . The specific microorganisms can enhance the intestinal epithelial barrier function, immune tolerance, maintain intestinal homeostasis, and reduce the occurrence of infection by down-regulating the expression of inflammatory factors. The intestinal flora can also maintain the ratio of helper T lymphocytes (Th) and reduce airway inflammation (Kao et al., 2020; Kreft et al., 2020) . The intestinal flora can promotes the preferential differentiation of anti-inflammatory Treg/Th2 cells while suppressing the relative differentiation of pro-inflammatory Th1/Th17 cells . Intestinal flora disorders can cause the dominant Th2 response. In general, the administration of targeted microecological preparations such as non-starch polysaccharides or related herbal medicines may have a specific preventive effect on SARS-CoV-2 infection .

For viral infections, though, overuse of antibiotics is ineffective and increases the patient's exposure to antibiotics in the short term. However, for patients with SARS-CoV-2 infection, especially patients with sepsis, empirical antibacterial treatment can be given within 1 h of the initial evaluation according to the China's Guidelines for the diagnosis and treatment of novel coronavirus pneumonia (version sixth). However, the colonization resistance of the intestine would be destroyed as soon as antibiotics treatment for pathogenic bacterial infections, caused profound and lasting changes in the intestinal flora. Antibiotics can cause changes in the intestinal flora, which can also lead to an increase in opportunistic pathogens (such as Clostridium difficile) and more likely to cause infections. The intestinal flora contains probiotics, which can prevent the colonization of pathogens. Antibiotic treatment destroys the structure of the intestinal flora and reduces resistance to pathogenic bacteria (Knight and Girling, 2003; . The metabolites of the intestinal flora can also affect the permeability of the host intestinal mucosa barrier (Arpaia et al., 2013) . The intestinal mucosal barrier not only participates in the intake of food nutrition and flora metabolites but also has a critical barrier function to prevent microbial invasion and inhibit the inflammatory response to the intestinal contents (Turner, 2009 ). The intestinal mucosal barrier includes continuous monolayer intestinal epithelial cells and the mucus they secrete. As the recognition site of intestinal microbes, intestinal epithelial cells often interact with microbes and their metabolites to promote the development of the intestinal immune system which participate in immune response and maintain the homeostasis of the intestinal flora (Cario and Podolsky, 2000; Eckburg et al., 2005) . The intestinal mucosal immune system is composed of the intestinal epithelium and various secretions on its surface, scattered immune cells, intestinal microbiota, and intestinal-related lymphoid tissues (Hooper et al., 2012) . In sepsis, the dysbiosis of intestinal flora will lead to changes in the physiological and anatomical structure of the intestinal mucosal barrier, the proliferation of intestinal cells is significantly reduced, and the apoptosis of intestinal villi and crypt cells is increased dramatically (Weinstein et al., 1975) . Intestinal flora and its metabolites play a significant role in maintaining the health of the body.

In patients with SARS-CoV-2 infection, early administration of microecological preparations and prebiotics can restore the balance of intestinal flora and strengthen the intestinal barrier, which is a crucial measure to avoid the aggravation of COVID-19 . In addition to damages the lungs, SARS-CoV-2 infection cause damage to multiple organs such as the gastrointestinal tract. The change of the intestinal flora is one of its essential pathophysiological mechanisms (Olaimat et al., 2020) . The use of prebiotics and herbal medicines with prebiotic effects regulate the intestinal flora, maintain the microecological balance of the gastrointestinal tract, improve the body's FIGURE 3 | Herbs with potential ACE2 receptor blockers, as well as related active ingredients and derivative prescriptions. We analyzed the most commonly used Chinese medicine prescriptions in the "Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia." Herbal medicines with potential ACE2 receptor blockers and related active ingredients have been sorted out.

Frontiers in Pharmacology | www.frontiersin.org July 2021 | Volume 12 | Article 646560 5 immunity, and reduce virus damage to the lungs (Heidari et al., 2021) . Prebiotics and herbs with prebiotic effects may help control the progression of severe COVID-19 patients and speed up the recovery process of patients infected with SARS-CoV-2.

Herbal Medicines as Angiotensin-Converting Enzyme

Angiotensin-converting enzyme 2 (ACE2) efficiently binds the S1 domain of the SARS-CoV S protein. ACE2 is a functional receptor for SARS-CoV. SARS-CoV-2 uses the SARS-CoV receptor ACE2 for entry and the serine protease TMPRSS2 for S protein priming. Several retrospective studies conducted on COVID-19 patients infected with SARS-CoV-2 pointed out that the combination of herbal medicine and Western medicine can significantly improve the clinical symptoms of COVID-19 patients and shorten the treatment time for patients in severe or critical condition Lee et al., 2021; Luo et al., 2021) . As show in Figure 2 , ACE2 is highly expressed in GI tract. Herbs are taken orally and absorbed through the intestine. It is important to understand which herbs and their active ingredients have potential inhibitory effects on ACE2. Here, we list the commonly used herbal prescriptions (Perez-Roses et al., 2015; Saranya et al., 2017; Chuan et al., 2020; Feng et al., 2020; Lin et al., 2020; Liu and Zhang, 2020; Ma J. et al., 2020; Ma Q. et al., 2020; Niu et al., 2020; Qu et al., 2020; Sen et al., 2020; Song et al., 2020; Sun K. et al., 2020; Tao et al., 2020; Wang S. et al., 2020; Wang et al., 2020b; Ya et al., 2020; Yao et al., 2020; Zhang et al., 2020b; Hong et al., 2021; Jia et al., 2021; Lin et al., 2021) in the "China Novel Coronavirus Pneumonia Diagnosis and Treatment Program." Among them, some herbs with potential ACE2-blockers and their related active ingredients are sorted out in Figure 3 . Research results show that the herbs as mentioned above may maintain the balance of RAS-related pathways (Saranya et al., 2017) , inhibit the activation of the complement system (Perez-Roses et al., 2015) , blunt inflammation , participate in immune regulation , inhibit the activity of SARS-CoV-2 3C-like protease (Chuan et al., 2020; Feng et al., 2020; Lin et al., 2020; Sen et al., 2020; Tao et al., 2020; Ya et al., 2020) , and inhibit the binding process of ACE2 Ma Q. et al., 2020; Niu et al., 2020; Song et al., 2020; Wang et al., 2020b) .

As mentioned above, restoring intestinal flora may help prevent and treat SARS-CoV-2 infections. In clinical practice, herbal medicines are usually extracted by water or ethanol and are mainly taken orally. An intestine is an important place for oral drugs to be metabolized in the body (Feng et al., 2019) . After the oral medication, they interact with a large number of microorganisms in the intestine (Hamasaki et al., 2000; Feng et al., 2019) . Some types of herbal medicines can regulate the intestinal flora's composition and metabolism, thereby improving the body's dysfunction and pathological conditions. The intestinal flora can participate in the metabolic transformation of herbs, and at the same time, can transform herbal compounds to improve bioavailability (Zuo et al., 2002) .

There are five main categories of herbal ingredients that can affect the intestinal flora, including glycoside, flavonoids, alkaloids, phenylpropanoids, and organic acids. The intestinal flora secretes glycoside hydrolases, lyases and esterases to cut sugar chains to obtain energy. An important type of product produced by polyglycolysis is short-chain fatty acids, including acetic acid, propionic acid and butyric acid. Short-chain fatty acids have a wide range of physiological function (Yang et al., 1996; Abdel-Hafez et al., 1998; Bae et al., 2004; Guo et al., 2012; Feng et al., 2015; Xia et al., 2016; Liu et al., 2019; Shao et al., 2019; Wang et al., 2021) . Most flavonoids (except flavanols) naturally combine with sugars to form β-glycosides, and only a small part of flavonoids is absorbed by the small intestine. Most of the glycosylated flavonoids will reach the colon and will be broken down into phenolic acid or other metabolites that can be absorbed by the body under the action of the colonic microflora. Flavonoids existing in the colon have a certain regulatory effect on the intestinal flora, and flavonoids catabolized by microorganisms can change their bioavailability and activity (Lee et al., 2004; Xiuwei et al., 2005; Taiming et al., 2006; Knaup et al., 2007; Shi et al., 2009; Trinh et al., 2010; Zhou et al., 2014; Zhou et al., 2015; Xin et al., 2019; Jin et al., 2020b; Wang et al., 2020a) . Alkaloids are a type of nitrogen-containing organic compounds derived from the biological world. They have significant physiological activities and are one of the important components of Chinese medicine. Some alkaloids have a certain degree of hydrophilicity and are also soluble in organic solvents. The structural characteristics of these alkaloids are often small molecules, ether bonds, coordination bonds, etc., which are prone to hydrolysis and dehydration reactions under the action of the intestinal flora (Ying et al., 2002; Weiming, 2005; Huaixia et al., 2006; Yufeng et al., 2008) . With a lactone structure, phenylpropanoids is easy to undergo biotransformation such as lactone hydrolysis or demethylation under the action of the intestinal flora (Jan et al., 2009; Zhao et al., 2009) . A small amount of organic acids is absorbed in the stomach and small intestine as a prototype, and then hydrolyzed under the action of the esterase of the intestinal mucosa and the intestinal flora for further metabolism. Intestinal bacteria can metabolize polyphenols or carbohydrates in the diet to produce organic acids (Weikao et al., 2008; Kim et al., 2013) . The production of organic acids is related to Clostridium, Escherichia coli, and Lactobacillus. Lactic acid can regulate intestinal peristalsis and inhibit the reproduction of harmful bacteria.

Here, we sort out some representative herbs that interact with the intestinal flora according to the types of active ingredients, as well as the possible mechanisms of the interaction of these herbs Frontiers in Pharmacology | www.frontiersin.org July 2021 | Volume 12 | Article 646560 6 (Bae et al., 2004; Xia et al., 2016) The intestinal flora secretes glycoside hydrolases, lyases and esterases to cut sugar chains to obtain energy. An important type of product produced by polyglycolysis is shortchain fatty acids, including acetic acid, propionic acid and butyric acid. Short-chain fatty acids have a wide range of physiological function. and effective ingredients with the intestinal flora. The interaction between the effective ingredients of traditional Chinese medicine and the intestinal flora are summarized in Table 1 .

Stable intestinal tight junction function is an important prerequisite for the stability of the intestinal mucosal barrier. It is closely related to tight junction protein including Occludin, ZO-1, and Claudin, and plays a key role in maintaining intestinal permeability. Tight junction protein is a critical protein that connects the gaps between cells and regulates the intestinal mucosa's permeability. Tight junctions have two main functions: 1) Maintain the polarity of cells, prevent the top and bottom sides of integral membrane proteins from spreading from the side; 2) Prevent ions and molecules from passing through Intercellular space. Under normal circumstances, the tightly connected structure is complete and the function is normal, but the structure and function will be destroyed under pathological conditions. Herbs relieve the destruction of intestinal epithelial cell tight junctions by proinflammatory cytokines (such as LPS, TNF-α, IFN-γ, IL), up-regulating tight expression junction proteins, and enhance the effect of mechanical barriers (Kim et al., 2009; Shah et al., 2010; Li et al., 2017) . There are quite a few herbs that can up-regulate Tight junction protein expression and reduce intestinal mucosal permeability. The active ingredients in the herbal medicine increase the expression level of tight junction protein, improve the ultrastructure of intestinal epithelial cells, up-regulate the ultrastructure of intestinal epithelial cells ZO-1 and Occludin expression, and then repair the colonic epithelial barrier and reduce Intestinal permeability (Lina et al., 2014) . Herbs can protect the intestinal mucosal immune barrier by regulating the levels of related cytokines (Pan et al., 2011; Liu et al., 2016) . The mechanism may be to regulate lymphocytes, reduce the level of inflammatory factor TNF-α, and improve the intestinal barrier damage (Dai et al., 2009; Zhang et al., 2012) . In China, many herbs have been clinically used to treat COVID-19. We searched for herbs that affected TJ protein from the "China Novel Coronavirus Pneumonia Diagnosis and Treatment Program" and the relevant data were shown in Table 2 .

In addition to protecting the integrity of the intestinal mucosa, herbal medicine also has a regulatory effect on the intestinal mucosa's immune function with a wide range of immunomodulatory effects. In recent years, extensive research on herbs' intestinal mucosal immunity has helped to reveal its mechanism of action (Yan et al., 2009; Cai et al., 2018) . Many herbal medicines, especially those that can restore intestinal flora, can increase the number of M cells in epithelial cells related to Peel's node follicles, promote the proliferation and activation of lymphocytes of Peel's node, and induce local mucosal immune response (Xu and Du, 2020) . In addition, herbal medicine can also increase the content of SIgA, IL-2, and IL-4 cytokines in intestinal mucosal proliferating immune cells, improve the body's immunity (Liu et al., 2003; Allam et al., 2015; Chen et al., 2016) , and improve the oxidative stress state of intestinal mucosa (Ghaffari et al., 2018; Ghaffari et al., 2019) . The presence of a large number of lymphocytes and cytokines near the intestinal mucosal epithelium is one of the important targets of herbal medicine (Tang and Li, 2014) . Lymphocytes are an important part of the immune system. Different lymphocytes have different functions. T lymphocytes participate in cellular immunity, among which regulatory T lymphocytes mainly maintain the homeostasis of intestinal mucosal immunity, and Th17 mainly defends against extracellular bacterial infections and mediates chronic inflammation. B lymphocytes participate in humoral immunity and can differentiate into plasma cells under the stimulation of antigens. NK lymphocytes can directly kill certain target cells. There are a large number of cytokines near the intestinal mucosal epithelium, including lymphokines, interleukin (IL), tumor necrosis factor (TNF), interferon (IFN) and so on (Pitman and Blumberg, 2000) . Herbal medicine has a good regulatory effect on intestinal immunity, and can regulate pro-inflammatory cytokines (IL-2, IFN-γ, TNF-α) and anti- Baicalin , Baicalein , Wogonin , Wogonoside (Huang S. et al., 2020) ZO-1, occludin, claudin-1, JAM-1 Alleviate the down-regulation of tight junction proteins

Quercetin ( Luteolin (Li B.-L. et al., 2021) ZO-2, claudin-3, claudin-4

The expression of occludin, claudin and ZO1 was increased by luteolin Citrus × aurantium L. [Rutaceae; aurantii fructus immaturus], Citrus medica L. [Rutaceae; citri sarcodactylis fructus] Naringenin (Noda et al., 2012) ZO-2, occludin, claudin-1,-3,-4

Increases the cytoskeletal association of ZO-2, occludin, and claudin-1, -3, and -4 Erianin occludin, claudin1

The expression of occluding and claudin1 in protein level were incresed Pterocarpus indicus Willd. [Fabaceae] Pterostilbene (Serreli et al., 2020) ZO-1, occludin Up-regulate the expression of ZO-1 and occludin Centella asiatica (L.) Urb. [Apiaceae; centellae herba] Asiatic Acid (Wróbel et al., 2020) ZO-1 Up-regulate the level of ZO-1 (Continued on following page) Frontiers in Pharmacology | www.frontiersin.org July 2021 | Volume 12 | Article 646560 inflammatory cytokines (IL-4, IL-5, IL-6, IL-10) Expression Yasui and Irahara, 2007) . The secretion balance of pro-inflammatory cytokines and anti-inflammatory cytokines is the guarantee for the body to produce a correct immune response. The immunomodulatory effect of herbal medicine on the body is one of the important mechanisms to prevent and treat intestinal mucosal damage. Herbs can affect the expression of IL-2, IL-4, IFN-γ, and SIg A in the intestinal mucosa, can increase the proliferation of mucosal cells and maintain the integrity of the intestinal mucosa (Zhang et al., 2010; Deng et al., 2018; Zhang M.-X. et al., 2019; Pu et al., 2020; Fang et al., 2021) . Herbal medicine, rich in a variety of biologically active ingredients and nutrients, achieves its immunomodulatory effect by activating macrophages, T lymphocytes, B lymphocytes and blood complement proteins. Herbs can reduce the intestinal inflammatory response, reduce intestinal inflammatory factors, and reduce the damage of intestinal epithelial cells by reducing the levels of TNF-α, IL-6 and other inflammatory factors (Zhang, 1984; Ou et al., 2017; Liu et al., 2018; Gao et al., 2019; Pang et al., 2021) .

Acute Respiratory Distress Syndrome and Multiple Organ Dysfunction Syndrome MODS refers to the occurrence of two or more system or organ dysfunctions or failures at the same time or sequentially after 24 h of acute damage to the body. It is a clinical syndrome in which multiple organ function changes in patients with acute injury cannot maintain a stable internal environment. MODS is dangerous and has a high mortality rate. Among the patients in severe or critical condition after infected by SARS-CoV-2, about two out of three patients will develop severely lifethreatening ARDS (Chiumello et al., 2020; Chivato Martin-Falquina et al., 2021) , manifested as sudden, stubborn, and rapidly progressing hypoxemia. The mortality rate is much higher. The occurrence of ARDS or MODS may involve the imbalance of intestinal flora Dickson et al., 2016) . The intestines and lungs are closely connected and affect each other. Under stress conditions such as trauma and infection in the body, the intestinal flora is unbalanced, releasing a large amount of active oxygen, and the intestinal barrier function is impaired (Lyte and Bailey, 1997; Souza et al., 2004) . The bacteria enter the blood and spread through the blood to other tissues or organs of the host, and finally cause a series of A cascade of inflammatory factors broke out and developed into severe sepsis, leading to ARDS (Anders et al., 2013; Dickson et al., 2016) . After the bacterial translocation, the lung is the first organ to be injured, indicating that intestinal infection is the inducement of acute lung injury. Studies have shown that mouse lung microbes transformed from Firmicutes and Proteus to pseudo-nematode community structure (Yajima et al., 2001) . In clinical trials, patients with acute respiratory distress syndrome (ARDS) have higher intestinal bacteria levels in bronchoalveolar lavage fluid, which is correlated with the degree of systemic inflammation (Dickson et al., 2016) . The primary source of pulmonary flora in sepsis patients may be the lower digestive tract, indicating that the intestinal flora is the bridge between the lungs and the intestines (Dickson et al., 2016) . However, the discovery that intestinal flora can cause lung infections may provide new ideas for preventing acute respiratory distress syndrome caused by SARS-CoV-2 infections.

The pathogenesis of MODS is currently unclear. However, the intestine is an important source of bacteria and endotoxins in patients in severe or critical condition, the intestine is one of the important sites for inflammatory cell activation and release of inflammatory mediators (Deng et al., 2001; van der Voort, 2006) . For the treatment of MODS, attention should be paid to the prevention and treatment of intestinal dysfunction. Herbal medicine has the following functions in preventing MODS. 1) Herbal medicine can strengthen the effect of enteral nutrition, enhance the body's immune protein synthesis, and more effectively improve the patient's serum protein, muscle, fat and other nutritional indicators (Yongbing et al., 2008; Hu et al., 2011; Pang et al., 2012; Zhang Q. et al., 2020) . Early enteral nutrition, especially nutrients with immunomodulatory components, can prevent intestinal mucosal atrophy and reduce the occurrence of bacterial translocation and sepsis. 2) Herbs can regulate the occludin and ZO- Vanillin occludin and ZO-1 Upregulation the expression of tight junction protein ZO-1 and occludin Ginkgo biloba L. [Ginkgoaceae; ginkgo semen]

Bilobalide ZO-1, Claudin-3, Occludin

Enhanced the expression of ZO-1, Claudin-3, Occludin

Frontiers in Pharmacology | www.frontiersin.org July 2021 | Volume 12 | Article 646560

intestinal flora, which can prevent the overgrowth and reproduction of Gram-negative bacteria (Wu Y.-R. et al., 2019; Liu Y.-T. et al., 2021) . 3) Herbal medicine has an antioxidant effect and can effectively reduce the damage of oxygen free radicals to cell membranes (Wu Y.-R. et al., 2019; Liu Y.-T. et al., 2021) . Herbs can also protect intestinal endothelial cells from oxygen free radical damage, prevent intestinal toxins from entering the blood circulation (Xiyu et al., 2006; Li M. et al., 2018) . 4) As mentioned above, herbal medicine can enhance the intestinal barrier function and prevent bacterial translocation. As the most extensive and crucial functional organ of the GI tract, the intestinal flora is bound to participate in specific complications' occurrence and development. In particular, some abnormal changes in the small intestine found on autopsy suggest the correlation between the SARS-CoV-2 infection and the intestinal flora. Of course, this correlation needs more research to confirm.

Sepsis is one of the main causes of death of patients in severe or critical condition, and its pathophysiological mechanism is more complicated. SARS-CoV-2 invades the body, produces proinflammatory and anti-inflammatory reactions, and releases a large number of inflammatory mediators to cause sepsis (Shi et al., 1999; Lin et al., 2000) . The intestine, as the largest "reservoir of bacteria" in the body, is considered to be the "priming" organ for sepsis-induced multiple organ dysfunction syndrome (Haseeb and Salwen, 2005) . The diversity and stability of the intestinal flora can enhance the host's defense capabilities. When sepsis occurs, the intestinal microenvironment changes, leading to pathological changes such as the destruction of intestinal epithelial cells, inflammatory reactions, and the invasion of pathogenic bacteria, which cause local and remote organ damage (Muller-Werdan and Werdan, 2003) . After an autopsy, it was found that the intestinal mucosal barrier of patients who died of COVID-19 was damaged (Varga et al., 2020) .

Most of the nutrient supply of intestinal epithelial cells comes from direct absorption from the intestinal lumen. The intestinal flora mainly depends on the intestinal nutrients to survive and participate in the metabolism of nutrients (Guarner and Malagelada, 2003) . Some polysaccharides and other ingredients in herbal medicine can be metabolized by bacteria into short-chain fatty acids (SFCA) (Rechkemmer et al., 1988; Huo et al., 2020) , including butyric acid, acetic acid, propionic acid, etc. Among them, butyric acid is helpful for the repair of intestinal mucosa and the prognosis of sepsis. SFCA can also be combined with G protein-coupled receptor (GPCR) to play a key role in promoting the stability of the intestinal environment and regulating inflammation. It also affects the function of dendritic cells and regulatory T lymphocytes and the secretion of IgA antibodies. Play an anti-inflammatory effect, thereby maintaining intestinal homeostasis. In conclusion, herbal medicine can maintain the intestinal microecological balance, prevent the migration of flora, and avoid the induction of endotoxemia, which is extremely important for the prevention and treatment of sepsis (Varon, 2009; Varon and Varon, 2015; Fan et al., 2020) . The gastrointestinal tract is considered the largest immunological organ in the body having a central role in regulating immune homeostasis (Takiishi et al., 2017) . The intestinal flora plays a vital role in the function regulation, immune defense, and material metabolism of the human body (Eckburg et al., 2005; Thaiss et al., 2016) . The intestinal mucosa has the function of producing immune tolerance and resisting pathogen invasion. Studies have shown that the intestinal flora can activate the TLR2, TLR3, TLR4, TLR7, and TLR9 signaling pathway (Cario and Podolsky, 2000; Szebeni et al., 2008; Heimesaat et al., 2010) and induce regulatory T cells (Treg). Tregs can negatively regulate the intensity and time of immune responses, and their abnormalities can lead to immune imbalance. The intestinal flora can also regulate helper T cells (Th) to induce the activation of neutrophils and intestinal epithelial cells (Wu et al., 2009; Wu et al., 2010; Geuking et al., 2011) . Intestinal flora can also stimulate B lymphocytes to produce inhibitory cytokines, thereby inhibiting the occurrence of inflammation. Therefore, intestinal flora can initiate the body's active immune response to invading microorganisms while maintaining its immune balance. Gut-Lung Axis intestinal immunity participates in the regulation of lung immunity and systemic immunity. The "gut-lung axis" refers to the fact that the intestinal flora can affect and regulate the lungs' immunity and function. Intestinal flora can induce inflammation in mice's lungs through Toll-Like receptor and promote the infiltration of neutrophils (Sato et al., 2020; Liao et al., 2021) . T helper 17 cells' intestinal induction is a critical step in mucosal protection (Gaboriau-Routhiau et al., 2009) , which can recruit neutrophils and promote the secretion of antibacterial factors by bronchial epithelium. Immunization of rat intestines by inactivated atypical Haemophilus influenzae can simultaneously increase the number of specific Th17 cells in mesenteric lymph nodes and airways (Essilfie et al., 2011; Olliver et al., 2011) . The production of specific antibodies in the respiratory tract coincides with the intestinal response to antigen exposure. Therefore, intestinal flora plays a significant role in the lung defense against microbial invasion (Jung et al., 1995; Hooper and Macpherson, 2010) . The immune transmission of the gastrointestinal and respiratory tracts can be achieved through mucosal immunity (Akbari et al., 2001; Aujla et al., 2008) . It means that in the treatment of COVID-19, the crucial role of intestinal flora in the regulation of the gut-lung axis should not be ignored.

Infectious lung diseases may cause pathological changes through the following two aspects. One is that immune disorders destroy the intestinal microecological disorders, leading to inflammation. As the intestinal cavity is exposed to many exogenous antigens, the immune system must be strictly controlled to maintain a symbiotic relationship with symbiotic bacteria. The host can distinguish beneficial microorganisms from harmful pathogens and establish a healthy microbial community. The mucosal immune system is responsible for removing pathogens. An inappropriate immune response in this process will destroy the intestines' homeostasis, cause microecological disorders, and lead to metabolic dysfunction and local or systemic inflammation (Williams, 2003; van Wijk and Cheroutre, 2010) . After mice are infected with the influenza virus, the intestinal flora becomes unbalanced and adaptive immune suppression, further aggravating lung inflammation . Also, the administration of antibiotics will cause the disturbance of the intestinal microflora, which will last for a long time. Changes in disease status are mainly caused by changing the susceptibility to infection, the colonization of antibiotic-resistant strains in the intestine, and resistance genes (Sartor, 2004; Buffie and Pamer, 2013) . The intestinal microecological imbalance can cause the conditional pathogenic bacteria in the intestine to move up to the oropharynx or lower respiratory tract, causing lower respiratory tract infection (Khalmatova, 2006) .

The microecological imbalance of the intestinal flora directly or indirectly promotes the occurrence and development, and severity of COPD. A large increase in Gram-negative bacilli will release endotoxin into the blood, and then return to the right atrium via the inferior vena cava, and perfused into the lungs via the pulmonary artery and capillaries. Endotoxin damage promotes the occurrence and development of COPD . The gut microbiota components, especially Gram-negative bacilli, are also the main species of the lung microbiota of COPD patients, and these bacteria can cause acute exacerbations of COPD (Sun Z. et al., 2020) . Herbs have beneficial effects in improving symptoms in stable COPD patients over a 3 month treatment period. The potential underlying mechanism may be attributable to the difference in gut microbiota among patients and by inhibiting Th17/Treg's ratio via restore gut microbiota .

Changes in microbial composition accompany bacterial and viral respiratory tract infections. Changes in the intestinal flora may promote the immune response dominated by respiratory allergies, thus playing an essential role in respiratory diseases' pathogenesis (Bjorksten et al., 2001) . Also, the increase in asthma risk is related to the rise in the number and abundance of Bacteroides fragilis and total anaerobes in the intestine . The intestinal composition flora of asthma patients has undergone significant changes. Herbal medicine can regulate the intestinal flora, thereby improving asthmatic airway inflammation (Fang et al., 2019; Le et al., 2020; Xueren et al., 2020) . Herbs can also regulate immune function through intestinal flora and are used to treat acute exacerbations of bronchial asthma (Huiyang et al., 2020) . By increasing the number of probiotics, reducing the number of harmful flora and restoring the flora's diversity, herbal medicine has certain advantages and effects in the treatment of intestinal microflora disorders and allergic asthma.

In many parts of the world, herbal medicine can be used to regulate and maintain the intestinal flora balance, thereby reducing the incidence of secondary bacterial infections. Due to hypoxia, inflammatory factors, and the use of antibacterial drugs, patients in severe or critical condition will have severe disturbances in the intestinal microenvironment, and critically ill patients are more likely to die from secondary bacterial infections. The "Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia" (fourth trial edition, trial fifth revised edition, sixth trial edition) [40] [41] [42] also mentioned the use of intestinal microecological regulators to maintain the intestinal flora Balance and prevent secondary bacterial infections. Many patients with mild COVID-19 chose to self-isolate at home to enhance their immunity and achieve self-healing. The immune function of patients is essential in defeating and clearing the virus. The gut microbiota in particular plays important roles in host metabolism, immunity and anti-inflammation. Herbs can restore the structure of the intestinal flora, which may further modulate the immune function after SARS-CoV-2 infection. Regulation of intestinal flora by herbal medicine may be helpful for the treatment and recovery of the disease (Figure 4) . Understanding the role of herbs that regulate intestinal flora in fighting respiratory virus infections and maintaining intestinal flora balance can provide new ideas for preventing and treating COVID-19.

LD and ZC conceived the paper. LD and YL wrote the manuscript. HX and YL contributed to the manuscript revision. 

Potent Anticonvulsant Paeonimetabolin-I Derivatives Obtained by Incubation of Paeoniflorin and Thiol Compounds with Lactobacillus Brevis

CD4+CD8+ and CD8α+β-T Lymphocytes in Human Small Intestinal Lamina Propria

Pulmonary Dendritic Cells Producing IL-10 Mediate Tolerance Induced by Respiratory Exposure to Antigen

Middle East Respiratory Syndrome Coronavirus: a Case-Control Study of Hospitalized Patients

Extracts from Peppermint Leaves, Lemon Balm Leaves and in Particular Angelica Roots Mimic the Pro-Secretory Action of the Herbal Preparation STW 5 in the Human Intestine

The Intestinal Microbiota, a Leaky Gut, and Abnormal Immunity in Kidney Disease

Metabolites Produced by Commensal Bacteria Promote Peripheral Regulatory T-Cell Generation

Epidemiological, Demographic, and Clinical Characteristics of 47 Cases of Middle East Respiratory Syndrome Coronavirus Disease from Saudi Arabia: A Descriptive Study

Hospital Outbreak of Middle East Respiratory Syndrome Coronavirus

IL-22 Mediates Mucosal Host Defense Against Gram-Negative Bacterial Pneumonia

Transformation of Ginseng Saponins to Ginsenoside Rh2 by Acids and Human Intestinal Bacteria and Biological Activities of Their Transformants

Allergy Development and the Intestinal Microflora during the First Year of Life

Clinical Features and Short-Term Outcomes of 144 Patients with SARS in the Greater Toronto Area

Microbiota-Mediated Colonization Resistance Against Intestinal Pathogens

Protective Effects of Enteral Nutrition Supplemented withCrassostrea hongkongensisPolysaccharides Against 5-Fluorouracil-Induced Intestinal Mucosal Damage in Rats

Total Glucosides of Paeony Restores Intestinal Barrier Function Through Inhibiting Lyn/Snail Signaling Pathway in Colitis Mice

Differential Alteration in Intestinal Epithelial Cell Expression of Toll-Like Receptor 3 (TLR3) and TLR4 in Inflammatory Bowel Disease

Clinical Characteristics and Laboratory Biomarkers Changes in COVID-19 Patients Requiring or Not Intensive or Sub-intensive Care: A Frontiers in Pharmacology | www

Short Term Outcome and Risk Factors for Adverse Clinical Outcomes in Adults With Severe Acute Respiratory Syndrome (SARS)

Wogonin Protects Human Retinal Pigment Epithelium Cells from LPS-Induced Barrier Dysfunction and Inflammatory Responses by Regulating the TLR4/NF-Κb Signaling Pathway

Structural Elucidation of a Novel Polysaccharide from Pseudostellaria Heterophylla and Stimulating Glucose Uptake in Cells and Distributing in Rats by Oral

Epidemiological and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: A Descriptive Study

Body Mass index and Acute Respiratory Distress Severity in Patients With and Without SARS-CoV-2 Infection

Acute Pancreatitis in SARS-CoV-2 Infection. Beyond Respiratory Distress

Outcomes and Prognostic Factors in 267 Patients with Severe Acute Respiratory Syndrome in Hong Kong

Mechanism Study of Matrine against SARS-CoV-2 Based on Network Pharmacology and Molecular Docking

Hosts and Sources of Endemic Human Coronaviruses

Epidemiology, Clinical Course, and Outcomes of Critically Ill Adults with COVID-19 in New York City: A Prospective Cohort Study

Treatment with Parenteral Nutrition Support and Chinese Herbs in One Case of Primary Small Intestinal Lymphangiectasia

The Role of Short-Chain Fatty Acids in the Interplay between Diet, Gut Microbiota, and Host Energy Metabolism

Prolonged Exposure to High Humidity and High Temperature Environment Can Aggravate Influenza Virus Infection through Intestinal flora and Nod/RIP2/NF-Κb Signaling Pathway

The Involvement of Multiple Protease-Antiprotease Systems and Gut Origin Sepsis in Zymosan-Associated Endothelial Barrier Injury and Multiple Organ Dysfunction in Rats

Magnolol and Honokiol Attenuate Apoptosis of Enterotoxigenic Escherichia Coli-Induced Intestinal Epithelium by Maintaining Secretion and Absorption Homeostasis and Protecting Mucosal Integrity

Gut Microbiota and Covid-19-Possible Link and Implications

Enrichment of the Lung Microbiome with Gut Bacteria in Sepsis and the Acute Respiratory Distress Syndrome

Diversity of the Human Intestinal Microbial flora

Haemophilus Influenzae Infection Drives IL-17-Mediated Neutrophilic Allergic Airways Disease

Application of Chinese Medicine in the Management of Critical Conditions: A Review on Sepsis

Effect of Lycium Barbarum Polysaccharide on Gut Microbiota in Allergic Asthmatic Mice

Effects of Qing Hua Chang Yin on Lipopolysaccharide induced Intestinal Epithelial Tight junction Injury in Caco2 Cells

Effects of Polysaccharides from Portulaca Oleracea L. On Intestinal Mucosal Cytokines and Intestinal flora in Mice with Ulcerative Colitis

Gut Microbiota, a New Frontier to Understand Traditional Chinese Medicines

Study on Mechanism of Shengmai Injection against Novel Coronavirus Pneumonia Based on Network Pharmacology and Molecular Docking Technology

The Key Role of Segmented Filamentous Bacteria in the Coordinated Maturation of Gut Helper T Cell Responses

Novel Drug Delivery Systems of Chinese Medicine for the Treatment of Inflammatory Bowel Disease

Impact of the

Intestinal Bacterial Colonization Induces Mutualistic Regulatory T Cell Responses

Effects of Turmeric and Chicory Seed Supplementation on Antioxidant and Inflammatory Biomarkers in Patients with Non-alcoholic Fatty Liver Disease (NAFLD)

Turmeric and Chicory Seed Have Beneficial Effects on Obesity Markers and Lipid Profile in Non-alcoholic Fatty Liver Disease (NAFLD)

Clinical Characteristics of Coronavirus Disease 2019 in China

Comorbidity and its Impact on 1590 Patients with COVID-19 in China: A Nationwide Analysis

Gut flora in Health and Disease

Regulatory Effects of Dendrobium Polysaccharides on Intestinal Dysbiosis: an Evaluation by PCR-DGGE

Highly Selective Antibacterial Activity of Novel Alkyl Quinolone Alkaloids from a Chinese Herbal Medicine, Gosyuyu

Collateral Damage: Sepsis-Induced Gut Injury

ACE2 Links Amino Acid Malnutrition to Microbial Ecology and Intestinal Inflammation

Comparative Infection Modeling and Control of COVID-19 Transmission Patterns in China

Ferulic Acid Ameliorates Lipopolysaccharide-Induced Barrier Dysfunction via MicroRNA-200c-3p-Mediated Activation of PI3K/AKT Pathway in Caco-2 Cells

Probiotics/ Prebiotics in Viral Respiratory Infections: Implication for Emerging Pathogens

MyD88/TLR9 Mediated Immunopathology and Gut Microbiota Dynamics in a Novel Murine Model of Intestinal Graft-Versus-Host Disease

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and is Blocked by a Clinically Proven Protease Inhibitor

Discussion on the Network Pharmacological Mechanism and Preliminary Evidence of Huopo Xialing Decoction for the Treatment of 2019-nCoV Inflammatory Storm by Integrating"Pathway-Target-Active Component

Interactions between the Microbiota and the Immune System

Immune Adaptations that Maintain Homeostasis with the Intestinal Microbiota

Review Article: Probiotics, Prebiotics and Dietary Approaches during COVID-19

Early Enteral Infusion of Traditional Chinese Medicine Preparation Can Effectively Promote the Recovery of Gastrointestinal Function after Esophageal Cancer Surgery

Effects of Compound Caoshi Silkworm Granules on Stable COPD Patients and Their Relationship with Gut Microbiota

Study on the Metabolism of Scopolamine in Rat Intestinal flora

Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan

Study on Active Compounds of Yupingfeng San for Preventing and Treating COVID-19 Based on Network Pharmacology and Molecular Docking Technology

Wogonoside Alleviates Colitis by Improving Intestinal Epithelial Barrier Function via the MLCK/pMLC2 Pathway

Effect of Modified Maxing Shigan Decoction on T Lymphocyte Subsets,inflammatory Factors and Intestinal flora in Children with Acute Exacerbation of Bronchial Asthma

Polysaccharide from Wild Morels Alters the Spatial Structure of Gut Microbiota and the Production of Short-Chain Fatty Acids in Mice

Malnutrition Promotes Rogue Bacteria

Biotransformation of Sesaminol Triglucoside to Mammalian Lignans by Intestinal Microbiota

Dissecting the Novel Mechanism of Reduning Injection in Treating Coronavirus Disease 2019 (COVID-19) Based on Network Pharmacology

Epidemiological, Clinical and Virological Characteristics of 74 Cases of Coronavirus-Infected Disease 2019 (COVID-19) with Gastrointestinal Symptoms

UPLC-MS Identification and Anticomplement Activity of the Metabolites of Sophora Tonkinensis Flavonoids Treated with Human Intestinal Bacteria

A Distinct Array of Proinflammatory Cytokines Is Expressed in Human colon Epithelial Cells in Response to Bacterial Invasion

Goat Milk Consumption Enhances Innate and Adaptive Immunities and Alleviates Allergen-Induced Airway Inflammation in Offspring Mice

Intestinal Microbiocenosis in Children with Thymomegaly and Acute Lower Respiratory Tract Infections and Regimen of its Correction

Banhabaikchulcheunma-tang Down-Regulates LPS-Induced Production of Pro-inflammatory Cytokines

Production of Hydroxycinnamoyl-Shikimates and Chlorogenic Acid in Escherichia coli: Production of Hydroxycinnamic Acid Conjugates

Eucalyptol Inhibits Amyloid-β-Induced Barrier Dysfunction in Glucose-Exposed Retinal Pigment Epithelial Cells and Diabetic Eyes

A Network-Based Pharmacology Study of Active Compounds and Targets of Fritillaria Thunbergii against Influenza

Identifying Active Compounds and Targets of Fritillariae Thunbergii against Influenza-Associated Inflammation by Network Pharmacology Analysis and Molecular Docking

Human Intestinal Hydrolysis of Phenol Glycosides -a Study with Quercetin Andp-Nitrophenol Glycosides Using Ileostomy Fluid

Gut flora in Health and Disease

Intestinal Microbiota Metabolism of L-Carnitine, a Nutrient in Red Meat, Promotes Atherosclerosis

From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites

Therapeutic Potential of the Intestinal Microbiota for Immunomodulation of Food Allergies

Advances and prospects of pharmacological activities of Dendrobium officinale Kimura et Migo polysaccharides

Traditional Chinese Herbal Medicine at the Forefront Battle against COVID-19: Clinical Experience and Scientific Basis

Gastrointestinal and Liver Manifestations in Patients with COVID-19

Antiallergic Activity of Hesperidin Is Activated by Intestinal Microflora

A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong

Luteolin Alleviates Ulcerative Colitis through SHP-1/STAT3 Pathway

Herbal Formula Xian-Fang-Huo-Ming-Yin Regulates Differentiation of Lymphocytes and Production of Pro-inflammatory Cytokines in Collagen-Induced Arthritis Mice

Bacteroides Thetaiotaomicron Relieves colon Inflammation by Activating Aryl Hydrocarbon Receptor and Modulating CD4+T Cell Homeostasis

Response to Char's Comment: Comment on Li et al: COVID-19 Patients' Clinical Characteristics, Discharge Rate, and Fatality Rate of Meta-Analysis

Discharge Rate, and Fatality Rate of Meta-analysis

Colistin and Amoxicillin Combinatorial Exposure Alters the Human Intestinal Microbiota and Antibiotic Resistome in the Simulated Human Intestinal Microbiota

Antioxidant Capacity Connection with Phenolic and Flavonoid Content in Chinese Medicinal Herbs

Main Active Components of Jiawei Gegen Qinlian Decoction Protects against Ulcerative Colitis under Different Dietary Environments in a Gut Microbiota-Dependent Manner

Potential Effect of Maxing Shigan Decoction against Coronavirus Disease 2019 (COVID-19) Revealed by Network Pharmacology and Experimental Verification

Diammonium Glycyrrhizinate Protects against Nonalcoholic Fatty Liver Disease in Mice through Modulation of Gut Microbiota and Restoration of Intestinal Barrier

Changes in Intestinal Microflora in Rats with Acute Respiratory Distress Syndrome

Traditional Chinese Herbal Medicine for Treating Novel Coronavirus (COVID-19) Pneumonia: Protocol for a Systematic Review and Meta-Analysis

Preparation of Anti Tolllike Receptor-4 Nano-Antibody and its Effect on Gram Negative Sepsis

Antihypercholesterolaemia, Antioxidant Activity and Free Radical Scavenger Effects of Traditional Chinese Medicine Prescriptions Used for Stroke

Exploring the Treatment of COVID -19 with Yinqiao Powder Based on Network Pharmacology

Exploring Potential Effect of Shengjiang San on SARS-CoV-2 Based on Network Pharmacology and Molecular Docking

Research Progress in Intervention of Intestinal Epithelial Function of Irritable Bowel Syndrome Patients by Herbal Medicine

Effects of Guchang Capsule on Dextran Sulphate Sodium-Induced Experimental Ulcerative Colitis in Mice

The Chinese Herbal Formula Zhibai Dihuang Granule Treat Yin-Deficiency-Heat Syndrome Rats by Regulating the Immune Responses

Gegen Qinlian Decoction Treats Diarrhea in Piglets by Modulating Gut Microbiota and Short-Chain Fatty Acids

Feasibility of Chaihu Dayuan Decoction in the Treatment of COVID-19 Based on

Protective Effect Ofangelica Sinensispolysaccharide on Experimental Immunological colon Injury in Rats

Vanillin Attenuates Cadmium-Induced Lung Injury through Inhibition of Inflammation and Lung Barrier Dysfunction through Activating AhR

Traditional Chinese Medicine, Liver Fibrosis, Intestinal flora: Is There Any Connection?-A Narrative Review

Alisol A 24-acetate Protects against Brain Microvascular Endothelial Cells Injury through Inhibiting miR-92a-3p/ Tight Junctions axis

Characteristics of Registered Clinical Trials on Traditional Chinese Medicine for Coronavirus Disease 2019 (COVID-19): A Scoping Review

Obacunone Protects against Ulcerative Colitis in Mice by Modulating Gut Microbiota, Attenuating TLR4/NF-Κb Signaling Cascades, and Improving Disrupted Epithelial Barriers

Neuroendocrine-bacterial Interactions in a Neurotoxin-Induced Model of Trauma

Study on Screening Chinese Traditional Medicine against 2019-nCoV Based on Mpro and PLP

Phillyrin (KD-1) Exerts Anti-viral and Anti-inflammatory Activities against Novel Coronavirus (SARS-CoV-2) and Human Coronavirus 229E (HCoV-229E) by Suppressing the Nuclear Factor Kappa B (NF-Κb) Signaling Pathway

Detection of the Human Coronavirus 229E, HKU1, NL63, and OC43 between 2010 and 2013 in Yamagata

Family Cluster of Middle East Respiratory Syndrome Coronavirus Infections

SARS-CoV-2 in Environmental Perspective: Occurrence, Persistence, Surveillance, Inactivation and Challenges

Network Pharmacology Analysis to Identify Phytochemicals in Traditional Chinese Medicines that May Regulate ACE2 for the Treatment of COVID-19

Differential Effects of Flavonoids on Barrier Integrity in Human Intestinal Caco-2 Cells

Descriptive Epidemiology and Characteristics of Confirmed Cases of Middle East Respiratory Syndrome Coronavirus Infection in the Makkah Region of Saudi Arabia

2014 MERS-CoV Outbreak in Jeddah -A Link to Health Care Facilities

The Potential Application of Probiotics and Prebiotics for the Prevention and Treatment of COVID-19

Intestinal Intraepithelial Lymphocytes: Sentinels of the Mucosal Barrier

Human Monocytes Promote Th1 and Th17 Responses to Streptococcus Pneumoniae

Thymol Improves Barrier Function and Attenuates Inflammatory Responses in Porcine Intestinal Epithelial Cells during Lipopolysaccharide (LPS)-Induced Inflammation

Polysaccharides from Arnebia Euchroma Ameliorated Endotoxic Fever and Acute Lung Injury in Rats through Inhibiting Complement System

Correlation of Total Salivary Secretory Immunoglobulin A (SIgA) and Mutans Specific SIgA in Children Having Different Caries Status

Clinical Characteristics of COVID-19 Patients with Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study

Anti-inflammatory Activity of Traditional Chinese Medicinal Herbs

Effects of Rhizome of Atractylodes Koreana (Nakai) Kitam on Intestinal flora and Metabolites in Rats with Rheumatoid Arthritis

Study on the Therapeutic Effects of Chinese Medicinal Formulae for Strengthening Spleen Combined with Enteral Nutrition Treatment

Beyond the Cardio-Renal Actions

Clinical Progression and Viral Load in a Community Outbreak of Coronavirus-Associated SARS Pneumonia: a Prospective Study

Coronavirus as a Possible Cause of Severe Acute Respiratory Syndrome

Xuanbai Chengqi Decoction Alleviates Pulmonary Inflammation in Mouse Model of Chronic Obstructive Pulmonary Disease through Inhibiting the Ratio of Th17/Treg via Gut Commensal Microbiota

Effect of Some Essential Oils on Phagocytosis and Complement System Activity

First Line of Defense: the Role of the Intestinal Epithelium as an Active Component of the Mucosal Immune System

Identification of Severe Acute Respiratory Syndrome in Canada

Effects of Benzoic Acid, Bacillus Coagulans and Oregano Oil Combined Supplementation on Growth Performance, Immune Status and Intestinal Barrier Integrity of Weaned Piglets

Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A Retrospective, Multi-Centre Case Series

Activation and Signaling Status of Human Lamina Propria T Lymphocytes

Influence of H7N9 Virus Infection and Associated Treatment on

Effects of Atractylodes Oil on Inflammatory Response and Serum Metabolites in Adjuvant Arthritis Rats

Evaluation of WHO Criteria for Identifying Patients with Severe Acute Respiratory Syndrome Out of Hospital: Prospective Observational Study

Fermentation of Polysaccharides and Absorption of Short Chain Fatty Acids in the Mammalian Hindgut

Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice

Clinical Aspects and Outcomes of 70 Patients with Middle East Respiratory Syndrome Coronavirus Infection: a Single-center Experience in Saudi Arabia

Microbiota-mitochondria Inter-talk: Consequence for Microbiota-Host Interaction

Angiotensin-(1-7) and Mas: New Players of the Renin-Angiotensin System

The Ace2/Angiotensin-(1-7)/Mas Axis of the Renin-Angiotensin System: Focus on Angiotensin

Morus alba Leaf Lectin (MLL) Sensitizes MCF-7 Cells to Anoikis by Inhibiting Fibronectin Mediated Integrin-FAK Signaling through Ras and Activation of P38 MAPK

Therapeutic Manipulation of the Enteric Microflora in Inflammatory Bowel Diseases: Antibiotics, Probiotics, and Prebiotics

Frontiers in Pharmacology | www.frontiersin.org

The Impact of Cell Maturation and Tissue Microenvironments on the Expression of Endosomal Toll-like Receptors in Monocytes and Macrophages

Repurposing Nimesulide, a Potent Inhibitor of the B0AT1 Subunit of the SARS-CoV-2 Receptor, as a Therapeutic Adjuvant of COVID-19

The Gut Microbiota Plays a Protective Role in the Host Defence against Pneumococcal Pneumonia

Identification of Potential Inhibitors of SARS-CoV-2 Main Protease and Spike Receptor from 10 Important Spices through Structure-Based Virtual Screening and Molecular Dynamic Study

Altered Paracellular Permeability in Intestinal Cell Monolayer Challenged with Lipopolysaccharide: Modulatory Effects of Pterostilbene Metabolites

Natural Products Inhibit LPS-Induced Activation of Pro-Inflammatory Cytokines in Peripheral Blood Mononuclear Cells

A Unique Polysaccharide from Hericium erinaceus Mycelium Ameliorates Acetic Acid-Induced Ulcerative Colitis Rats by Modulating the Composition of the Gut Microbiota, Short Chain Fatty Acids Levels and GPR41/43 Respectors

Microecology Research: A New Target for the Prevention of Asthma

Influence ofCoptis Chinensison Pharmacokinetics of Flavonoids after Oral Administration ofRadix Scutellariaein Rats

Association of Cardiac Injury with Mortality in Hospitalized Patients with COVID-19 in Wuhan

Fast Repair of Hydroxy Radical Purine Deoxynucleotide Adducts by Phenylpropanoid Glycosides and Their Derivatives from Chinese Herbs

Screening Novel Inhibitors Targeting SARS-CoV-2 S Protein-ACE2 Interaction Based on Molecular Docking

The Essential Role of the Intestinal Microbiota in Facilitating Acute Inflammatory Responses

Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses

Clinical Characteristics and Morbidity Associated with Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit

Network Pharmacological Analysis and Mechanism Prediction of Xiaochaihu Decoction in Treatment of COVID-19 with Syndrome of Pathogenic Itieat Lingering in Lung and Obstructive Cardinalate

Dynamic Changes of Gut and Lung Microorganisms during Chronic Obstructive Pulmonary Disease Exacerbations

Quercetin Enhances Intestinal Barrier Function through the Assembly of Zonnula Occludens-2, Occludin, and Claudin-1 and the Expression of Claudin-4 in Caco-2 Cells

Kaempferol Enhances Intestinal Barrier Function through the Cytoskeletal Association and Expression of Tight junction Proteins in Caco-2 Cells

Increased Expression of Toll-like Receptor (TLR) 2 and TLR4 in the Colonic Mucosa of Children with Inflammatory Bowel Disease

Absorption Characteristics of Baicalin and Baicalein in Rat Small Intestine

Intestinal Barrier and Gut Microbiota: Shaping Our Immune Responses throughout Life

Tryptophan Dietary Impacts Gut Barrier and Metabolic Diseases

Detection of Novel Coronavirus by RT-PCR in Stool Specimen from Asymptomatic Child

Future View and Development of Immunology: Exploring the Immunology Based on Chinese Medicine and Culture

Investigate Mechanism of Jinzhen Oral Liquid for Prevention COVID-19 Based on

The Microbiome and Innate Immunity

Antipruritic Effect of Baicalin and its Metabolites, Baicalein and Oroxylin A, in Mice

A Cluster of Cases of Severe Acute Respiratory Syndrome in Hong Kong

Linking Gut-Associated Lymphoid Tissue to Multiple Organ Dysfunction Syndrome and Infection

Mucosal T Cells in Gut Homeostasis and Inflammation

Endothelial Cell Infection and Endotheliitis in COVID-19

Shenfu, Traditional Chinese Medicine in Sepsis: Are We Ready for it?

Herbal Medicine in Acute Care Medicine: Past, Present, and Future?

Selective Death of T Cell Receptor γ/δ+ Intraepithelial Lymphocytes by Apoptosis

Human Intestine Luminal ACE2 and Amino Acid Transporter Expression Increased by ACE-Inhibitors

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

The Effect of Microbial Composition and Proteomic on Improvement of Functional Frontiers in Pharmacology | www

Constipation by Chrysanthemum Morifolium Polysaccharide

Mechanism of Xuanbai Chengqi Decoction in the Treatment of Severe COVID-19 Case Based on Network Pharmacology and Literature Screening

Effects of Mulberry Leaf Flavonoids on Intestinal Mucosal Morphology and Intestinal Flora of Litopenaeus Vannamei

Discussion of Pharmacological Mechanism and Component Compatibility of Five Chinese Medicines Targeting ACE2 for Treatment of COVID-19 Using Network Pharmacology

Clinical Features of 69 Cases with Coronavirus Disease

The In Vivo Process of Chlorogenic Acid and Drug Interaction

Study on the Chemical Constituents of Sinomenium Chinensis and the Metabolism of Sinomenine in Rats

Antimicrobial Therapy of Experimental Intraabdominal Sepsis

Autopsy Findings and Venous Thromboembolism in Patients with COVID-19

Portal to the interior: Viral Pathogenesis and Natural Compounds that Restore Mucosal Immunity and Modulate Inflammation

Asiatic Acid, a Natural Compound that Exerts Beneficial Effects on the Cystometric and Biochemical Parameters in the Retinyl Acetate-Induced Model of Detrusor Overactivity

Gut-Residing Segmented Filamentous Bacteria Drive Autoimmune Arthritis via T Helper 17 Cells

Effect of Catechin on Dietary AGEs Absorption and Cytotoxicity in Caco2 Cells

Curcumin Ameliorates Ischemic Stroke Injury in Rats by Protecting the Integrity of the Blood brain Barrier

A Human Colonic Commensal Promotes colon Tumorigenesis via Activation of T Helper Type 17 T Cell Responses

Paeoniflorin Prevents Intestinal Barrier Disruption and Inhibits Lipopolysaccharide (LPS)-Induced Inflammation in Caco-2 Cell Monolayers

Pathological Relationship between Intestinal Flora and Osteoarthritis and Intervention Mechanism of Chinese Medicine

Study on Relationship between Traditional Chinese Medicine and Cytokines

Metabolism of Six Saponins by Rat Intestinal Bacteria In Vitro

Protective Effect of Magnolol on Oxaliplatin-induced Intestinal Injury in Mice

The Intestinal Absorption Properties of Flavonoids in Hippophaë Rhamnoides Extracts by an In Situ Single-Pass Intestinal Perfusion Model

The Role of Human Coronavirus Infection in Pediatric Acute Gastroenteritis

The Biotransformation of Kaempferitrin by Human Intestinal flora

Recent Advances of Antioxidant Activity of Chinese Herbal Medicines

Shenmai Injection Maintains Blood-Brain Barrier Integrity Following Focal Cerebral Ischemia via Modulating the Expression and Trafficking of Occludin in Lipid Rafts

Management of Corona Virus Disease-19 (COVID-19): The Zhejiang Experience

Effective Treatment of Severe COVID-19 Patients with Tocilizumab

Effects of Lentinan on Endothelial Cell Activity, Inflammatory Response, Endoplasmic Reticulum Stress, and Apoptosis in Sepsis

Effect of Shen Ling Baizhu Powder on Airway Inflammation and Regulation of Gut Microbiota in Asthmatic Mice

To Investigation of the Mechanism of Xuebijing Injection in COVID-19 Treatment Based on Network Pharmacology and Molecular Docking

Bacterial Translocation in Neonatal Rats: The Relation between Intestinal flora, Translocated Bacteria, and Influence of Milk

Effects of Four Polysaccharides on Mucosal Immunity in Vaccinated Chickens

Purification and Characterization of a Novel Sennoside-Hydrolyzing .BETA.-Glucosidase from Bifidobacterium Sp. Strain SEN, a Human Intestinal Anaerobe

Potential Material Basis of Kangbingdu Granules for Treatment of Coronavirus Disease 2019 (COVID-19) Based on Network Pharmacology and Molecular Docking Technology

Effects of Traditional Chinese Medicine on

MERS, SARS and Other Coronaviruses as Causes of Pneumonia

Study on Metabolites of Aconitine in Rabbit Urine

Influences of Enteral Nutrition Combined with TCM Intervention on Inflammation and Intestinal Barrier Function in Severe Acute Pancreatitis in Rabbits

ACE2 Contributes to the Maintenance of Mouse Epithelial Barrier Function

Studies on the Biotransformation of Aconitine in Human Intestinal Bacteria Using Soft-Ionization Mass Spectrometry

Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia

Therapeutic Mechanisms of Traditional Chinese Medicine to Improve Metabolic Diseases via the Gut Microbiota

The Alleviating Effect and Mechanism of Bilobalide on Ulcerative Colitis

Clinical Characteristics of 140 Patients Infected with SARS-CoV-2 in Wuhan

The TLR4-MyD88-NF-Κb Pathway is Involved in sIgA-Mediated IgA Nephropathy

Protective Effects of Baicalin on Peritoneal Tight Junctions in Piglets Challenged with Glaesserella Parasuis

Superior Intestinal Integrity and Limited Microbial Translocation Are Associated with Lower Immune Activation in SIVmac239-Infected Northern Pig-Tailed Macaques (Macaca Leonina)

Effects of Sijunzi Decoction on Small Intestinal T Lymphocyte Subsets Differentiation in Reserpine Induced Spleen Deficiency Rats

Clinical Effect of the Traditional Chinese Medicine for Invigorating the Spleen and Activating the Internal Circulation Combined with the Enteral Nutrition Support on the Postoperative Recovery of Gastric Cancer

Erianin Alleviates Diabetic Retinopathy by Reducing Retinal Inflammation Initiated by Microglial Cells via Inhibiting Hyperglycemia-mediated ERK1/2-Nf-κb Signaling Pathway

Effect of Danshen on Apoptosis and NF-Kappa B Protein Expression of the Intestinal Mucosa of Rats with Severe Acute Pancreatitis or Obstructive Jaundice

Exploring Mechanism of Qingkailing Injection in Treatment of Coronavirus Disease 2019 (COVID-19) Based on Network Pharmacology and Molecular Docking

Aloe Emodin Relieves Ang II-induced Endothelial junction Dysfunction via Promoting Ubiquitination Mediated NLRP3 Inflammasome Inactivation

Application of C3 Determination in the Treatment of Pulmonary Cancer by Traditional Chinese Medicine

Studies on the Biotransformation of Arctigenin Using Electrospray Ionization Mass Spectrometry

Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: a Retrospective Cohort Study

A Comparative Study on the Metabolism of Epimedium Koreanum Nakai-Prenylated Flavonoids in Rats by an Intestinal Enzyme (Lactase Phlorizin Hydrolase) and Intestinal Flora

Intestinal Absorption and Metabolism of Epimedium Flavonoids in Osteoporosis Rats

The Influence of Intestinal flora on Asthma and COPD:Research advance

Alisol B 23-Acetate Ameliorates Azoxymethane/Dextran Sodium Sulfate-Induced Male Murine Colitis-Associated Colorectal Cancer via Modulating the Composition of Gut Microbiota and Improving Intestinal Barrier

Houttuynia Cordata Polysaccharides Ameliorate Pneumonia Severity and Intestinal Injury in Mice with Influenza Virus Infection

Metabolism of Constituents in Huangqin-Tang, a Prescription in Traditional Chinese Medicine, by Human Intestinal flora

Alterations in Fecal Fungal Microbiome of Patients with COVID-19 during Time of Hospitalization until Discharge

We thank Ray Liu for the helpful comments on the manuscript.

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.Copyright © 2021 Chen, Lv, Xu and Deng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.